VolitionRX Ltd. engages in the development of blood-based cancer tests to help diagnose a range of cancers. Its products include the Nucleosomics platform that identifies and measures nucleosomes in the bloodstream or other bodily fluids. The company was founded on September 24, 1998 and is headquartered in Henderson, NV.
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Reynolds Cameron John | President and CEO | Nov 17 '25 | Buy | 0.35 | 20,000 | 7,000 | 2,554,847 | Nov 17 01:12 PM |
| Reynolds Cameron John | President and CEO | Oct 14 '25 | Buy | 0.51 | 110,000 | 56,100 | 2,534,847 | Oct 15 04:05 PM |
| Innes Guy Archibald | Director | Oct 14 '25 | Buy | 0.51 | 96,153 | 49,038 | 1,062,967 | Oct 15 04:05 PM |
| STILL TIMOTHY I | Director | Oct 14 '25 | Buy | 0.51 | 48,076 | 24,519 | 1,535,458 | Oct 15 04:05 PM |
| Reynolds Cameron John | President and CEO | Sep 12 '25 | Buy | 0.66 | 15,000 | 9,885 | 2,624,847 | Sep 15 09:00 AM |